SCHEMBL25870609

SCHEMBL25870609

COC(=O)OC1CCC2C3C(C)CC4=CC(O)CCC4C3CCC12C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 4/20 0.51
▸ MAPT P10636 3/20 0.39
▸ LMNA P02545 3/20 0.39
▸ PGR P06401 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ NR3C2 P08235 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ SHBG P04278 5/20 0.34
▸ ESR1 P03372 1/20 0.34
▸ NR1I2 O75469 1/20 0.34
▸ CYP19A1 P11511 2/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ BRCA1 P38398 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ SLC22A1 O15245 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25865371 1.00 AR (0.51) ARMAPTLMNAPGRMEN1
SCHEMBL11791747 0.90 AR (0.50) ARMAPTLMNAMEN1KMT2A
SCHEMBL24102904 0.85 AR (0.69) ARMAPTLMNAPGRNR3C2
SCHEMBL24102896 0.85 AR (0.69) ARMAPTLMNAPGRNR3C2
SCHEMBL24102620 0.85 AR (0.69) ARMAPTLMNAPGRNR3C2
SCHEMBL11801553 0.83 AR (0.58) ARMAPTLMNAPGRMEN1
SCHEMBL6446239 0.82 MAPT (0.51) ARMAPTLMNAPGRMEN1
SCHEMBL11791701 0.82 AR (0.48) ARMAPTLMNAPGRNR3C2
SCHEMBL6441434 0.82 MAPT (0.51) ARMAPTLMNAPGRMEN1
SCHEMBL11794626 0.81 AR (0.48) ARMAPTLMNAPGRNR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227492-A1 MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME THE USA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-07-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227492-A1 MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME SHBG, CYP19A1, GNRHR AR 7/4885MAPT 4428/4885LMNA 388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback